Achievements and obstacles of remyelinating therapies in multiple sclerosis.

about

mTORC1 is transiently reactivated in injured nerves to promote c-Jun elevation and Schwann cell dedifferentiation.Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches The Role of Diet in Multiple Sclerosis: Mechanistic Connections and Current Evidence

P2860

Q52563031-0D6960C7-6BD3-43A1-90B2-6AB641DE8102 Q58737028-0BB20F72-5A45-4E9D-B936-59E0B4046A7C Q58772726-44D90151-8310-46AD-BB16-989A9C1984DD

P2860

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Item

http://www.wikidata.org/entity/Q47835493

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@en

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@nl

type

Item

label

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@en

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@nl

prefLabel

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@en

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

@nl

P1476

Achievements and obstacles of remyelinating therapies in multiple sclerosis

@en

P2093

Martin Stangel

http://www.w3.org/2001/XMLSchema#string

Paul M Matthews

http://www.w3.org/2001/XMLSchema#string

Tanja Kuhlmann

http://www.w3.org/2001/XMLSchema#string

P2860

Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes

The Role of Astrocytes in Multiple Sclerosis Progression

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Control of autoimmune CNS inflammation by astrocytes

Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation

Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling

LINGO-1 negatively regulates myelination by oligodendrocytes

Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS

F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation

Diffusion Tensor Imaging of the Brain

P2888

nrneurol.2017.139

P304

742-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2017.139

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Trevor Kilpatrick

P577

2017-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29146953

http://www.w3.org/2001/XMLSchema#string

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

about

P2860

P2860

Achievements and obstacles of remyelinating therapies in multiple sclerosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698